Leishmaniasis of the tongue in a renal transplant recipient.
Alrajhi
A A
AA
Department of Medicine, King Faisal Specialist Hospital, Riyadh, Saudi Arabia.
Saleem
M
M
Ibrahim
E A
EA
Gramiccia
M
M
D000666:Amphotericin B / Q000627:therapeutic use; D000818:Animals; D000981:Antiprotozoal Agents / Q000627:therapeutic use; D006801:Humans; D016867:Immunocompromised Host; D017964:Itraconazole / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000009:adverse effects*; D007893:Leishmania donovani / Q000302:isolation & purification*; D007897:Leishmaniasis, Mucocutaneous / Q000188:drug therapy / Q000469:parasitology*; D008081:Liposomes; D008297:Male; D008875:Middle Aged; D014059:Tongue / Q000469:parasitology* / Q000473:pathology; D014060:Tongue Diseases / Q000188:drug therapy / Q000469:parasitology* / Q000473:pathology; D016896:Treatment Outcome
D000981:Antiprotozoal Agents; D008081:Liposomes; D017964:Itraconazole; D000666:Amphotericin B